Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/23236
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSegelov, Eva-
dc.contributor.authorUnderhill, Craig-
dc.contributor.authorPrenen, Hans-
dc.contributor.authorKarapetis, Christos-
dc.contributor.authorJackson, Christopher-
dc.contributor.authorNott, Louise-
dc.contributor.authorClay, Tim-
dc.contributor.authorPavlakis, Nick-
dc.contributor.authorSabesan, Sabe-
dc.contributor.authorHeywood, Ellen-
dc.contributor.authorSteer, Christopher-
dc.contributor.authorLethborg, Carrie-
dc.contributor.authorGan, Hui K-
dc.contributor.authorYip, Desmond-
dc.contributor.authorKaranth, Narayan-
dc.contributor.authorKarikios, Deme-
dc.contributor.authorMacIntyre, C Raina-
dc.date2020-05-13-
dc.date.accessioned2020-05-18T06:53:43Z-
dc.date.available2020-05-18T06:53:43Z-
dc.date.issued2020-08-20-
dc.identifier.citationJCO oncology practice 2020; 16(8): 467-482en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/23236-
dc.description.abstractCancer has become a prevalent disease, affecting millions of new patients globally each year. The COVID-19 pandemic is having far-reaching impacts around the world, causing substantial disruptions to health and health care systems that are likely to last for a prolonged period. Early data have suggested that having cancer is a significant risk factor for mortality from severe COVID-19. A diverse group of medical oncologists met to formulate detailed practical advice on systemic anticancer treatments during this crisis. In the context of broad principles, issues including risks of treatment, principles of prioritizing resources, treatment of elderly patients, and psychosocial impact are discussed. Detailed treatment advice and options are given at a tumor stream level. We must maintain care for patients with cancer as best we can and recognize that COVID-19 poses a significant competing risk for death that changes conventional treatment paradigms.en
dc.language.isoeng-
dc.subjectCOVID-19en
dc.titlePractical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic.en
dc.typeJournal Articleen
dc.identifier.journaltitleJCO oncology practiceen
dc.identifier.affiliationBiosecurity Program, Kirby Institute, University of New South Wales, Sydney, New South Wales, Australiaen
dc.identifier.affiliationDepartment of Medicine, University of Otago, Dunedin, New Zealanden
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationAustin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Medical Oncology, The Canberra Hospital and ANU Medical School, Australian National University, Canberra, Australian Capital Territory, Australiaen
dc.identifier.affiliationDepartment of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australiaen
dc.identifier.affiliationDepartment of Medical Oncology, Nepean Hospital and Nepean Clinical School, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australiaen
dc.identifier.affiliationDepartment of Oncology, Monash University and Monash Health, Melbourne, Victoria, Australiaen
dc.identifier.affiliationBorder Medical Oncology, Albury-Wodonga Regional Cancer Centre, and University of NSW Rural Clinical School, Albury Campus, Albury, New South Wales, Australiaen
dc.identifier.affiliationDepartment of Medical Oncology, Flinders Medical Centre, Flinders University, Adelaide, South Australia, Australiaen
dc.identifier.affiliationCancer Services, Monash Health, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Medical Oncology, Royal Hobart Hospital, Hobart, Tasmania, Australiaen
dc.identifier.affiliationDepartment of Oncology, St John of God Subiaco Hospital and School of Medicine and Health Sciences, Edith Cowan University, Perth, Western Australia, Australiaen
dc.identifier.affiliationDepartment of Medical Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australiaen
dc.identifier.affiliationDepartment of Medical Oncology, Townsville Cancer Centre, Townsville Hospital and Health Services, Townsville, Queensland, Australiaen
dc.identifier.affiliationInclusive Health Research, St Vincent's Health Australia, Melbourne, Victoria, Australiaen
dc.identifier.affiliationLa Trobe University School of Cancer Medicine, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Oncology, University Hospital Antwerp, Edegem, Belgium..en
dc.identifier.doi10.1200/OP.20.00229en
dc.type.contentTexten
dc.identifier.pubmedid32401686-
dc.type.austinJournal Article-
local.name.researcherGan, Hui K
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptMedical Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

20
checked on Jun 13, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.